The new indication allows durvalumab, in combination with carboplatin and paclitaxel, to be used as a first-line treatment ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

The 76-year-old, last month, revealed he has been diagnosed with skin cancer for the 'second time in three years' and has ...

A man who binged on energy drinks and chocolate was given a stark warning by his doctor 18 months ago. Then aged 50, Richard ...

A daily medication relied on by more than half a million women is under urgent recall after a critical test failure raised ...

Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the 'Company”), a late-stage clinical biopharmaceutical company focused on the ...

Gut health may play a crucial role in protecting us from the harmful effects of PFAS – toxic and long-lasting "forever ...

Oncternal could receive up to $65 million in milestones if the programs are successful. Regulatory events account for $40 ...